As noted, endogenous GLP-1 has a very short half-life of 12 min because it is rapidly degraded by the enzyme DPP-4, which results in low systemic levels
Its quite complex, and it actually needs multifaceted care, just like what we talk about with type 2 diabetes or heart disease as an example
Schedule a consultation to discuss Semaglutide, Tirzepatide, oral options, labs, and ongoing support
This understanding can help you identify triggers and help you develop strategies to stop food cravings
However, the lower dose of semaglutide used and a focus on patient-reported outcomes rather than on cardiovascular events are limitations of STEP-HFpEF DM
Common issues include nausea, vomiting, diarrhoea, constipation, and stomach discomfort